(Q33908993)

29 July 2017

1 reference

title

Polysaccharide vaccines for preventing serogroup A meningococcal meningitis. (English)

1 reference

29 July 2017

Polysaccharide vaccines for preventing serogroup A meningococcal meningitis (English)

0 references

1 reference

1 reference

meningococcal meningitis

1 reference

M Patel

1

1 reference

29 July 2017

C K Lee

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

2001

0 references

published in

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

3

0 references

page(s)

CD001093

1 reference

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001093

Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001093

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001093

When can odds ratios mislead?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001093

Assessing vaccine efficacy in the field. Further observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001093

Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001093

Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001093

Group A meningococcal disease in the U.S. Pacific Northwest: epidemiology, clinical features, and effect of a vaccination control program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001093

Enhancement of the immune response to meningococcal polysaccharide vaccine in a malaria endemic area by administration of chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001093

Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001093

A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001093

10.1002/14651858.CD001093

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference